GENERAL AMERICAN INVESTORS CO INC - INTRA CELLULAR THERAPIES INC ownership

INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 241 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.

Quarter-by-quarter ownership
GENERAL AMERICAN INVESTORS CO INC ownership history of INTRA CELLULAR THERAPIES INC
ValueSharesWeighting
Q3 2023$13,566,268
-17.7%
260,4390.0%1.22%
-15.3%
Q2 2023$16,490,997
+16.9%
260,4390.0%1.44%
+7.6%
Q1 2023$14,102,772
-6.0%
260,439
-8.1%
1.33%
-9.1%
Q4 2022$14,999,592
+13.7%
283,4390.0%1.47%
+7.0%
Q3 2022$13,188,000
-18.5%
283,4390.0%1.37%
-15.6%
Q2 2022$16,179,000
-6.7%
283,4390.0%1.62%
+14.8%
Q1 2022$17,344,000
+16.9%
283,4390.0%1.42%
+21.8%
Q4 2021$14,835,000
+13.4%
283,439
-19.2%
1.16%
+4.9%
Q3 2021$13,078,000
-8.7%
350,8040.0%1.11%
-7.5%
Q2 2021$14,320,000
+21.4%
350,804
+1.0%
1.20%
+8.9%
Q1 2021$11,791,000
+6.7%
347,4970.0%1.10%
+0.7%
Q4 2020$11,050,000
+23.9%
347,4970.0%1.09%
+6.2%
Q3 2020$8,917,000
+30.3%
347,497
+30.4%
1.03%
+18.5%
Q2 2020$6,842,000
+67.0%
266,5270.0%0.87%
+56.4%
Q1 2020$4,097,000
-64.0%
266,527
-19.6%
0.56%
-46.7%
Q4 2019$11,375,000
+345.9%
331,527
-2.9%
1.04%
+313.5%
Q3 2019$2,551,000
-34.5%
341,527
+13.9%
0.25%
-31.7%
Q2 2019$3,893,000
+6.6%
299,9420.0%0.37%
+1.9%
Q1 2019$3,653,000
+6.9%
299,9420.0%0.36%
+0.8%
Q4 2018$3,416,000299,9420.36%
Other shareholders
INTRA CELLULAR THERAPIES INC shareholders Q1 2022
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 175,000$9,115,75010.70%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 317,856$16,547,5835.57%
Deep Track Capital, LP 2,600,000$135,434,0005.23%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,369,849$71,355,4343.86%
SILVERARC CAPITAL MANAGEMENT, LLC 208,730$10,872,7463.30%
DCF Advisers, LLC 107,157$5,581,8083.04%
Bellevue Group AG 3,170,250$165,138,3232.66%
Vahanian & Associates Financial Planning Inc. 15,217$792,6542.55%
Iron Triangle Partners LP 330,549$17,218,2972.52%
TANG CAPITAL MANAGEMENT LLC 300,000$15,627,0002.20%
View complete list of INTRA CELLULAR THERAPIES INC shareholders